T Effector Gene Signature on IMpower150: Is There a Better Biomarker than PD-L1 for Immunotherapy? (BMIC-021) - 102204

Spotlight
Video

T Effector Gene Signature on IMpower150: Is There a Better Biomarker than PD-L1 for Immunotherapy? (BMIC-021)

BeaconMedIC has 29 videos Subscribe Here

Loading........
Description: Dr. Jack West reviews provocative biomarker results on the IMpower150 trial that tested atezolizumab with carboplatin/paclitaxel +/- bevacizumab & revealed strongest benefit of atezo in those with T effector gene signature high expression or high PD-L1.
Shared By : BeaconMedIC
Posted on : 12/22/17
Added : 4 months ago
Category : Immunotherapy